- 专利标题: System and method for personalized transdermal drug delivery
-
申请号: US16124856申请日: 2018-09-07
-
公开(公告)号: US11532389B1公开(公告)日: 2022-12-20
- 发明人: Michal Knas , Jiby John
- 申请人: MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
- 申请人地址: US MA Springfield
- 专利权人: MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
- 当前专利权人: MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
- 当前专利权人地址: US MA Springfield
- 代理机构: Foley & Lardner LLP
- 主分类号: B33Y30/00
- IPC分类号: B33Y30/00 ; B29C64/20 ; G16H20/17 ; A61K9/70 ; A61M37/00 ; G16H80/00
摘要:
A transdermal delivery device for dispensing personalized transdermal dosage formulations from a plurality of reservoirs, and a personalized method for producing the transdermal delivery device. A prescription fill service receives electronic prescription data for a plurality of transdermal dosage formulations to be administered to a given patient. The prescription fill service deposits transdermal dosage formulations in two or more reservoirs of a transdermal device substrate via 3D printing of printable pharmaceutical agent. The electronic prescription data may include transdermal dosage formulations data used to select printable pharmaceutical agent deposited in respective reservoirs. The electronic prescription data further may include medication regimen data for administration of transdermal medications, such as timing data for release of selected transdermal dosage formulations. In an embodiment, a finished transdermal delivery device includes barriers formed at reservoir openings, a controller, and a controlled energy source that degrades the barriers to actuate release of reservoir contents.
信息查询